Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines

A. D'Cruz, T. Lin, A. K. Anand, D. Atmakusuma, M. J. Calaguas, I. Chitapanarux, ByoungChul Cho, B. C. Goh, Y. Guo, W. S. Hsieh, C. Hu, D. Kwong, J. C. Lin, P. J. Lou, T. Lu, K. Prabhash, V. Sriuranpong, P. Tang, V. V. Vu, I. WahidK. K. Ang, A. T. Chan

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Head and neck cancer (HNC) is a disease of the upper aerodigestive tract and is one of the most frequently diagnosed cancers worldwide. A high rate of cancers involving the head and neck are reported across the Asian region, with notable variations between countries. Disease prognosis is largely dependent on tumor stage and site. Patients with early stage disease have a 60-95% chance of cure with local therapy. Early diagnosis and appropriate treatment are important to increase the likelihood of cure and survival. However, the majority of patients present with locally advanced disease and require multimodality treatment. This necessitates, a multidisciplinary approach which is essential to make appropriate treatment decisions, particularly with regards to tolerability, costs, available infrastructure and quality of life issues. Unfortunately, majority of the studies that dictate current practice have been developed in the west where diseases biology, patient population and available infrastructure are very different from those in the Asian continent. With this in mind an expert panel of Head and Neck Oncologists was convened in May 2012 to review the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) clinical practice guidelines and develop practical recommendations on the applicability of these guidelines on the management of head and neck cancer for Asian patients. The objective of this review and consensus meeting was to suggest revisions, to account for potential differences in demographics and resources, to the NCCN and ESMO guidelines, to better reflect current clinical management of head and neck cancer within the Asian region for health care providers. These recommendations, which reflect best clinical practice within Asia, are expected to benefit practitioners when making decisions regarding optimal treatment strategies for their patients.

Original languageEnglish
Pages (from-to)872-877
Number of pages6
JournalOral Oncology
Volume49
Issue number9
DOIs
Publication statusPublished - 2013 Sep 1

Fingerprint

Head and Neck Neoplasms
Guidelines
Practice Guidelines
Neoplasms
Therapeutics
Medical Oncology
Health Personnel
Early Diagnosis
Consensus
Decision Making
Neck
Head
Quality of Life
Demography
Costs and Cost Analysis
Survival
Population

All Science Journal Classification (ASJC) codes

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

D'Cruz, A., Lin, T., Anand, A. K., Atmakusuma, D., Calaguas, M. J., Chitapanarux, I., ... Chan, A. T. (2013). Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines. Oral Oncology, 49(9), 872-877. https://doi.org/10.1016/j.oraloncology.2013.05.010
D'Cruz, A. ; Lin, T. ; Anand, A. K. ; Atmakusuma, D. ; Calaguas, M. J. ; Chitapanarux, I. ; Cho, ByoungChul ; Goh, B. C. ; Guo, Y. ; Hsieh, W. S. ; Hu, C. ; Kwong, D. ; Lin, J. C. ; Lou, P. J. ; Lu, T. ; Prabhash, K. ; Sriuranpong, V. ; Tang, P. ; Vu, V. V. ; Wahid, I. ; Ang, K. K. ; Chan, A. T. / Consensus recommendations for management of head and neck cancer in Asian countries : A review of international guidelines. In: Oral Oncology. 2013 ; Vol. 49, No. 9. pp. 872-877.
@article{9d1277ca2d7f4139bd019e63fe20a927,
title = "Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines",
abstract = "Head and neck cancer (HNC) is a disease of the upper aerodigestive tract and is one of the most frequently diagnosed cancers worldwide. A high rate of cancers involving the head and neck are reported across the Asian region, with notable variations between countries. Disease prognosis is largely dependent on tumor stage and site. Patients with early stage disease have a 60-95{\%} chance of cure with local therapy. Early diagnosis and appropriate treatment are important to increase the likelihood of cure and survival. However, the majority of patients present with locally advanced disease and require multimodality treatment. This necessitates, a multidisciplinary approach which is essential to make appropriate treatment decisions, particularly with regards to tolerability, costs, available infrastructure and quality of life issues. Unfortunately, majority of the studies that dictate current practice have been developed in the west where diseases biology, patient population and available infrastructure are very different from those in the Asian continent. With this in mind an expert panel of Head and Neck Oncologists was convened in May 2012 to review the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) clinical practice guidelines and develop practical recommendations on the applicability of these guidelines on the management of head and neck cancer for Asian patients. The objective of this review and consensus meeting was to suggest revisions, to account for potential differences in demographics and resources, to the NCCN and ESMO guidelines, to better reflect current clinical management of head and neck cancer within the Asian region for health care providers. These recommendations, which reflect best clinical practice within Asia, are expected to benefit practitioners when making decisions regarding optimal treatment strategies for their patients.",
author = "A. D'Cruz and T. Lin and Anand, {A. K.} and D. Atmakusuma and Calaguas, {M. J.} and I. Chitapanarux and ByoungChul Cho and Goh, {B. C.} and Y. Guo and Hsieh, {W. S.} and C. Hu and D. Kwong and Lin, {J. C.} and Lou, {P. J.} and T. Lu and K. Prabhash and V. Sriuranpong and P. Tang and Vu, {V. V.} and I. Wahid and Ang, {K. K.} and Chan, {A. T.}",
year = "2013",
month = "9",
day = "1",
doi = "10.1016/j.oraloncology.2013.05.010",
language = "English",
volume = "49",
pages = "872--877",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "9",

}

D'Cruz, A, Lin, T, Anand, AK, Atmakusuma, D, Calaguas, MJ, Chitapanarux, I, Cho, B, Goh, BC, Guo, Y, Hsieh, WS, Hu, C, Kwong, D, Lin, JC, Lou, PJ, Lu, T, Prabhash, K, Sriuranpong, V, Tang, P, Vu, VV, Wahid, I, Ang, KK & Chan, AT 2013, 'Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines', Oral Oncology, vol. 49, no. 9, pp. 872-877. https://doi.org/10.1016/j.oraloncology.2013.05.010

Consensus recommendations for management of head and neck cancer in Asian countries : A review of international guidelines. / D'Cruz, A.; Lin, T.; Anand, A. K.; Atmakusuma, D.; Calaguas, M. J.; Chitapanarux, I.; Cho, ByoungChul; Goh, B. C.; Guo, Y.; Hsieh, W. S.; Hu, C.; Kwong, D.; Lin, J. C.; Lou, P. J.; Lu, T.; Prabhash, K.; Sriuranpong, V.; Tang, P.; Vu, V. V.; Wahid, I.; Ang, K. K.; Chan, A. T.

In: Oral Oncology, Vol. 49, No. 9, 01.09.2013, p. 872-877.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Consensus recommendations for management of head and neck cancer in Asian countries

T2 - A review of international guidelines

AU - D'Cruz, A.

AU - Lin, T.

AU - Anand, A. K.

AU - Atmakusuma, D.

AU - Calaguas, M. J.

AU - Chitapanarux, I.

AU - Cho, ByoungChul

AU - Goh, B. C.

AU - Guo, Y.

AU - Hsieh, W. S.

AU - Hu, C.

AU - Kwong, D.

AU - Lin, J. C.

AU - Lou, P. J.

AU - Lu, T.

AU - Prabhash, K.

AU - Sriuranpong, V.

AU - Tang, P.

AU - Vu, V. V.

AU - Wahid, I.

AU - Ang, K. K.

AU - Chan, A. T.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Head and neck cancer (HNC) is a disease of the upper aerodigestive tract and is one of the most frequently diagnosed cancers worldwide. A high rate of cancers involving the head and neck are reported across the Asian region, with notable variations between countries. Disease prognosis is largely dependent on tumor stage and site. Patients with early stage disease have a 60-95% chance of cure with local therapy. Early diagnosis and appropriate treatment are important to increase the likelihood of cure and survival. However, the majority of patients present with locally advanced disease and require multimodality treatment. This necessitates, a multidisciplinary approach which is essential to make appropriate treatment decisions, particularly with regards to tolerability, costs, available infrastructure and quality of life issues. Unfortunately, majority of the studies that dictate current practice have been developed in the west where diseases biology, patient population and available infrastructure are very different from those in the Asian continent. With this in mind an expert panel of Head and Neck Oncologists was convened in May 2012 to review the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) clinical practice guidelines and develop practical recommendations on the applicability of these guidelines on the management of head and neck cancer for Asian patients. The objective of this review and consensus meeting was to suggest revisions, to account for potential differences in demographics and resources, to the NCCN and ESMO guidelines, to better reflect current clinical management of head and neck cancer within the Asian region for health care providers. These recommendations, which reflect best clinical practice within Asia, are expected to benefit practitioners when making decisions regarding optimal treatment strategies for their patients.

AB - Head and neck cancer (HNC) is a disease of the upper aerodigestive tract and is one of the most frequently diagnosed cancers worldwide. A high rate of cancers involving the head and neck are reported across the Asian region, with notable variations between countries. Disease prognosis is largely dependent on tumor stage and site. Patients with early stage disease have a 60-95% chance of cure with local therapy. Early diagnosis and appropriate treatment are important to increase the likelihood of cure and survival. However, the majority of patients present with locally advanced disease and require multimodality treatment. This necessitates, a multidisciplinary approach which is essential to make appropriate treatment decisions, particularly with regards to tolerability, costs, available infrastructure and quality of life issues. Unfortunately, majority of the studies that dictate current practice have been developed in the west where diseases biology, patient population and available infrastructure are very different from those in the Asian continent. With this in mind an expert panel of Head and Neck Oncologists was convened in May 2012 to review the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) clinical practice guidelines and develop practical recommendations on the applicability of these guidelines on the management of head and neck cancer for Asian patients. The objective of this review and consensus meeting was to suggest revisions, to account for potential differences in demographics and resources, to the NCCN and ESMO guidelines, to better reflect current clinical management of head and neck cancer within the Asian region for health care providers. These recommendations, which reflect best clinical practice within Asia, are expected to benefit practitioners when making decisions regarding optimal treatment strategies for their patients.

UR - http://www.scopus.com/inward/record.url?scp=84883133202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883133202&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2013.05.010

DO - 10.1016/j.oraloncology.2013.05.010

M3 - Review article

C2 - 23830839

AN - SCOPUS:84883133202

VL - 49

SP - 872

EP - 877

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 9

ER -